Genetically Predicted Serum Albumin and Risk of Colorectal Cancer: A Bidirectional Mendelian Randomization Study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Arnold M, Abnet CC, Neale RE, et al. Global Burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335–349 e15. doi:10.1053/j.gastro.2020.02.068
   PubMed Web of Science ®Google Scholar
• Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300(23):2765–2778. doi:10.1001/jama.2008.839
   PubMed Web of Science ®Google Scholar
• Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011;22(9):1958–1972. doi:10.1093/annonc/mdq653
   PubMed Web of Science ®Google Scholar
• Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54. doi:10.3322/caac.21440
   PubMed Web of Science ®Google Scholar
• Park Y, Hunter DJ, Spiegelman D, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005;294(22):2849–2857. doi:10.1001/jama.294.22.2849
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–578. doi:10.1016/s0140-6736(08)60269-x
   PubMed Web of Science ®Google Scholar
• Yao Y, Suo T, Andersson R, et al. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev. 2017;1(1):Cd003430. doi:10.1002/14651858.CD003430.pub2
   Web of Science ®Google Scholar
• Sun LC, Chu KS, Cheng SC, et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009;9:288. doi:10.1186/1471-2407-9-288
   PubMed Web of Science ®Google Scholar
• Dixon MR, Haukoos JS, Udani SM, et al. Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg. 2003;138(9):962–966. doi:10.1001/archsurg.138.9.962
   Google Scholar
• González-Trejo S, Carrillo JF, Carmona-Herrera DD, et al. Baseline serum albumin and other common clinical markers are prognostic factors in colorectal carcinoma: a retrospective cohort study. Medicine. 2017;96(15):e6610. doi:10.1097/md.0000000000006610
   Web of Science ®Google Scholar
• He MM, Fang Z, Hang D, et al. Circulating liver function markers and colorectal cancer risk: a prospective cohort study in the UK Biobank. Int J Cancer. 2021;148(8):1867–1878. doi:10.1002/ijc.33351
   Web of Science ®Google Scholar
• Ghuman S, Van Hemelrijck M, Garmo H, et al. Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer. 2017;116(10):1358–1365. doi:10.1038/bjc.2017.96
   PubMed Web of Science ®Google Scholar
• Kuhn T, Sookthai D, Graf ME, et al. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017;117(10):1572–1579. doi:10.1038/bjc.2017.313
   Web of Science ®Google Scholar
• McMillan DC, Watson WS, O’Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer. 2001;39(2):210–213. doi:10.1207/S15327914nc392_8
   PubMed Web of Science ®Google Scholar
• Ishigaki K, Akiyama M, Kanai M, et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet. 2020;52(7):669–679. doi:10.1038/s41588-020-0640-3
   PubMed Web of Science ®Google Scholar
• Auton A, Brooks LD, Durbin RM; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68–74. doi:10.1038/nature15393
   PubMed Web of Science ®Google Scholar
• Zhou W, Nielsen JB, Fritsche LG, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018;50(9):1335–1341. doi:10.1038/s41588-018-0184-y
   PubMed Web of Science ®Google Scholar
• Kanai M, Akiyama M, Takahashi A, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390–400. doi:10.1038/s41588-018-0047-6
   PubMed Web of Science ®Google Scholar
• Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34(8):816–834. doi:10.1002/gepi.20533
   Web of Science ®Google Scholar
• Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–1998. doi:10.1093/ije/dyx102
   PubMed Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–665. doi:10.1002/gepi.21758
   PubMed Web of Science ®Google Scholar
• Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–R208. doi:10.1093/hmg/ddy163
   PubMed Web of Science ®Google Scholar
• Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698. doi:10.1038/s41588-018-0099-7
   PubMed Web of Science ®Google Scholar
• Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961–1974. doi:10.1093/ije/dyw220
   PubMed Web of Science ®Google Scholar
• Yarmolinsky J, Bonilla C, Haycock PC, et al. Circulating selenium and prostate cancer risk: a Mendelian Randomization analysis. J Natl Cancer Inst. 2018;110(9):1035–1038. doi:10.1093/jnci/djy081
   Google Scholar
• Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43(3):922–929. doi:10.1093/ije/dyu005
   Web of Science ®Google Scholar
• Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734–1739. doi:10.1093/ije/dyx034
   PubMed Web of Science ®Google Scholar
• Yang Z, Zheng Y, Wu Z, et al. Association between pre-diagnostic serum albumin and cancer risk: results from a prospective population-based study. Cancer Med. 2021;10(12):4054–4065. doi:10.1002/cam4.3937
   PubMed Web of Science ®Google Scholar
• Fischer K, Kettunen J, Wurtz P, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med. 2014;11(2):e1001606. doi:10.1371/journal.pmed.1001606
   Web of Science ®Google Scholar
• Ko WF, Helzlsouer KJ, Comstock GW. Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. J Natl Cancer Inst. 1994;86(24):1874–1875. doi:10.1093/jnci/86.24.1874
   Google Scholar
• Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989;2(8677):1434–1436. doi:10.1016/s0140-6736(89)92042-4
   PubMed Web of Science ®Google Scholar
• Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6–19. doi:10.1136/gutjnl-2017-314924
   PubMed Web of Science ®Google Scholar
• Al-Shaiba R, McMillan DC, Angerson WJ, Leen E, McArdle CS, Horgan P. The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer. 2004;91(2):205–207. doi:10.1038/sj.bjc.6601886
   Web of Science ®Google Scholar
• Halliwell B. Albumin–an important extracellular antioxidant? Biochem Pharmacol. 1988;37(4):569–571. doi:10.1016/0006-2952(88)90126-8
   PubMed Web of Science ®Google Scholar
• Ferrer R, Mateu X, Maseda E, et al. Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients. Expert Rev Clin Pharmacol. 2018;11(2):125–137. doi:10.1080/17512433.2018.1412827
   PubMed Web of Science ®Google Scholar
• Janney A, Powrie F, Mann EH. Host-microbiota maladaptation in colorectal cancer. Nature. 2020;585(7826):509–517. doi:10.1038/s41586-020-2729-3
   PubMed Web of Science ®Google Scholar
• Li SKH, Martin A. Mismatch repair and colon cancer: mechanisms and therapies explored. Trends Mol Med. 2016;22(4):274–289. doi:10.1016/j.molmed.2016.02.003
   PubMed Web of Science ®Google Scholar
• Grimm G, Haslacher H, Kampitsch T, et al. Sex differences in the association between albumin and all-cause and vascular mortality. Eur J Clin Invest. 2009;39(10):860–865. doi:10.1111/j.1365-2362.2009.02189.x
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-310912
   PubMed Web of Science ®Google Scholar